Table 2 The complications or comorbidities of NEC infants treated (with/without) probiotics in this study
From: Probiotics may not prevent the deterioration of necrotizing enterocolitis from stage I to II/III
Variables | Total (n = 231) | Before matching | After matchinga | ||||
|---|---|---|---|---|---|---|---|
With (n = 108) | Without (n = 123) | P | With (n = 81) | Without (n = 81) | P | ||
NRDS, %(n) | 7.4 (17) | 8.3 (9) | 6.5 (8) | 0.595 | 7.4 (6) | 6.2 (5) | 0.755 |
Apnea, %(n) | 6.1 (14) | 8.3 (9) | 4.1 (5) | 0.175 | 6.2 (5) | 3.7 (3) | 0.717 |
Respiratory failure, %(n) | 16.0 (37) | 14.8 (16) | 17.1 (21) | 0.641 | 13.6 (11) | 16.0 (13) | 0.658 |
Pulmonary hemorrhage, %(n) | 5.2 (12) | 4.6 (5) | 5.7 (7) | 0.717 | 4.9 (4) | 7.4 (6) | 0.514 |
Sepsis, %(n) | 31.2 (72) | 37.0 (40) | 26.0 (32) | 0.071 | 39.5 (32) | 32.1 (26) | 0.325 |
Septic shock, %(n) | 2.6 (6) | 1.9 (2) | 3.3 (4) | 0.552 | 2.5 (2) | 4.9 (4) | 0.677 |
Bacterial meningitis, %(n) | 4.3 (10) | 3.7 (4) | 4.9 (6) | 0.910 | 3.7 (3) | 7.4 (6) | 0.493 |
Congenital heart diseaseb, %(n) | 44.2 (102) | 45.4 (49) | 43.1 (53) | 0.728 | 46.9 (38) | 46.9 (38) | 1.000 |
Cardiac insufficiency, %(n) | 1.3 (3) | 1.9 (2) | 0.8 (1) | 0.910 | 1.2 (1) | 1.2 (1) | 1.000 |
MODS,%(n) | 0.4 (1) | 0 (0) | 0.8 (1) | 1.000a | 0 (0) | 1.2 (1) | 1.000a |
Anemia, %(n) | 68.8 (159) | 79.6 (86) | 59.3 (73) | 0.001 | 76.5 (62) | 60.5 (49) | 0.028 |
Coagulation disorder, %(n) | 59.3 (137) | 63.9 (69) | 55.3 (68) | 0.184 | 61.7 (50) | 55.6 (45) | 0.425 |
Thrombocytopenia, %(n) | 21.2 (49) | 22.2 (24) | 20.3 (25) | 0.725 | 23.5 (19) | 23.5 (19) | 1.000 |